Obeticholic acid, a Farensoid‐X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
Rajeshwar Mookerjee, Gautam Mehta, Rajiv Jalan – 13 March 2014
Reply
James E. Everhart, Constance E. Ruhl – 13 March 2014
Is there a straightforward relationship between hepatitis C virus infection and diabetes?
Pan Zhao, Zhenman Wei, Wanshu Liu – 13 March 2014
Quick diagnosis of hepatic encephalopathy: Fact or fiction?
Sara Montagnese, Sami Schiff, Piero Amodio – 13 March 2014
Wow, that portal vein is small: Preventing portal vein thrombosis in liver transplantation for small children
Michael J. Englesbe, Amit K. Mathur, Seth A. Waits, John C. Magee – 12 March 2014
Identification of MicroRNA‐214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression
Dong‐liang Chen, Zhi‐qiang Wang, Zhao‐lei Zeng, Wen‐jing Wu, Dong‐sheng Zhang, Hui‐yan Luo, Feng Wang, Miao‐zhen Qiu, De‐shen Wang, Chao Ren, Feng‐hua Wang, Lucia J. Chiao, Helene Pelicano, Peng Huang, Yu‐hong Li, Rui‐hua Xu – 11 March 2014 – The purpose of this study was to identify microRNAs (miRNAs) involved in the pathology of colorectal cancer (CRC) liver metastasis and investigate their underlying mechanisms.
Rebleeding prophylaxis improved outcomes in patients with hepatocellular carcinoma: Is it feasible in all patients?
Ping‐Hsien Chen, Ming‐Chih Hou – 11 March 2014
E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr‐1/SHP/EID1 network
Yuxia Zhang, Ningyi Xu, Jun Xu, Bo Kong, Bryan Copple, Grace L. Guo, Li Wang – 11 March 2014 – E2F transcription factor 1 (E2F1) is an important regulator of metabolic diseases; however, its role in liver function remains elusive. This study unraveled a regulatory cascade involving E2F1, early growth response‐1 (Egr‐1), nuclear receptor small heterodimer partner (SHP, NR0B2), and EIA‐like inhibitor of differentiation 1 (EID1) in cholestatic liver fibrosis.
Sinusoidal endothelial cells direct traffic at the intersection of regeneration and fibrosis
Robert C. Huebert, Vijay H. Shah – 11 March 2014
Angiotensin‐II type 1 receptor‐mediated Janus kinase 2 activation induces liver fibrosis
Michaela Granzow, Robert Schierwagen, Sabine Klein, Benita Kowallick, Sebastian Huss, Markus Linhart, Irela G. Reza Mazar, Jan Görtzen, Annabelle Vogt, Frank A. Schildberg, Maria A. Gonzalez‐Carmona, Alexandra Wojtalla, Benjamin Krämer, Jacob Nattermann, Sören V. Siegmund, Nikos Werner, Dieter O. Fürst, Wim Laleman, Percy Knolle, Vijay H. Shah, Tilman Sauerbruch, Jonel Trebicka – 11 March 2014 – Activation of the renin angiotensin system resulting in stimulation of angiotensin‐II (AngII) type I receptor (AT1R) is an important factor in the development of liver fibrosis.